Ras, ROS and Proteotoxic Stress: A Delicate Balance
Authors:
- 1 September 2011
- journal article
- editorial
- Published by Elsevier in Cancer Cell
- Vol. 20 (3) , 281-282
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Exploiting Cancer Cell Vulnerabilities to Develop a Combination Therapy for Ras-Driven TumorsCancer Cell, 2011
- Novel insights into the role of HSP90 in cytoprotection of H2S against chemical hypoxia-induced injury in H9c2 cardiac myocytesInternational Journal of Molecular Medicine, 2011
- New druggable targets in the Ras pathway?2010
- Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicityProceedings of the National Academy of Sciences, 2010
- Clinical and genetic aspects of neurofibromatosis 1Genetics in Medicine, 2010
- Predicting drug susceptibility of non–small cell lung cancers based on genetic lesionsJournal of Clinical Investigation, 2009
- The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transitionOncogene, 2007
- Suppression of the mTOR-Raptor Signaling Pathway by the Inhibitor of Heat Shock Protein 90 GeldanamycinThe Journal of Biochemistry, 2006
- Targeting RAS signalling pathways in cancer therapyNature Reviews Cancer, 2003
- Heat Shock Protein 90 Modulates the Unfolded Protein Response by Stabilizing IRE1αMolecular and Cellular Biology, 2002